Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...

Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.

PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio said the U.S. Food and Drug Administration has cleared its ...

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

So far, the BCMA-targeted CAR has shown early success in four Australian multiple myeloma patients in a Phase I trial.

Researchers from the Fritz Haber Institute of the Max Planck Society have unveiled fundamental new insights into the working principles of fuel-cell catalysts. Catalysts are indispensable for our ...

The gray portion of this schematic represents a nanodisc, where for the first time researchers were able to replicate the native membrane environment (red dots) of a T-cell receptor (cyan). Credit: ...

This video outlines a beginner’s path from novice to advanced, emphasizing why skipping foundational steps can slow progress or lead to setbacks. Learn how to build skills in the right order, develop ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...